Thermal properties of electrodeposited bismuth telluride nanowires embedded in amorphous alumina

3 pages, 3 figures.Bismuth telluride nanowires are of interest for thermoelectric applications because of the predicted enhancement in the thermoelectric figure-of-merit in nanowire structures. In this letter, we carried out temperature-dependent thermal diffusivity characterization of a 40 nm diameter Bi2Te3 nanowires/alumina nanocomposite. Measured thermal diffusivity of the composite decreases from 9.2×10–7 m2 s–1 at 150 K to 6.9×10–7 m2 s–1 at 300 K and is lower than thermal diffusivity of unfilled alumina templates. Effective medium calculations indicate that the thermal conductivity along nanowires axis is at least an order of magnitude lower than thermal conductivity of the bulk bismuth telluride.G.C. would like to acknowledge financial support from JPL and DOE. M.S.M.G. acknowledges a fellowship awarded by the MCYT (Spain) in the Ramon y Cajal Program.Peer reviewe

Observation of an oxygen isotope effect in YBa\u3csub\u3e2\u3c/sub\u3eCu\u3csub\u3e3\u3c/sub\u3eO\u3csub\u3e7\u3c/sub\u3e

A small decrease in Tc of 0.3 K to 0.5 K is observed when as much as 90% of the 16O in YBa2Cu3O7 is substituted with18O. This result is consistent with our observation that there is an oxygen isotope effect in La1.85Sr0.15CuO4, but in contrast with previous reports that there is no isotope effect for YBa2Cu3O7. This new result suggests that phonons play an important role in the electron-pairing mechanism in YBa2Cu3O7

Search for Isotope Effect in Superconducting Y-Ba-Cu-O

An isotope effect has been searched for in the high-Tc, superconductor YBa2Cu307 —b through substitution of 180 for 16O. No shift in the superconducting transition temperature T, is observed by electrical resistivity or magnetic susceptibility measurements. We discuss the implications of this result for mechanisms of superconductivity in the high-T, oxides

Observation of an Isotope Shift in the Superconducting Transition Temperature of La\u3csub\u3e1.85\u3c/sub\u3eSr\u3csub\u3e0.15\u3c/sub\u3eCuO\u3csub\u3e4\u3c/sub\u3e

An oxygen isotope shift is observed in superconducting La1.85Sr0.15CuO4 when 18O is substituted partially for 16O; the superconducting transition temperature Tc is lowered by 0.3 to 1.0 K in different samples. We examine these results using conventioanl phonon-mediated BCS theory and conclude that, for La1.85Sr0.15CuO4, phonons play an important role in the pairing mechanism

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two

Background The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd. Methods We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background. Results First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001). Conclusions In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival